Complete genome sequences of Helicobacter pylori clarithromycin-resistant strains

Genome Announcements

Volumn 1, Issue 6, 2013, Pages

  Binh, Tran Thanh ^a   Suzuki, Rumiko ^a   Shiota, Seiji ^a   Kwon, Dong Hyeon ^b   Yamaoka, Yoshio ^a,c  

^a OITA UNIVERSITY   (Japan)

^b LONG ISLAND UNIVERSITY   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84999767761     PISSN: None     EISSN: 21698287     Source Type: Journal    
DOI: 10.1128/genomeA.00912-13     Document Type: Article

References (14)

1. Peek RM, Jr, Blaser MJ. 2002. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2:28-37.
2. Suerbaum S, Michetti P. 2002. Helicobacter pylori infection. N. Engl. J. Med. 347:1175-1186.
3. Hosking SW, Ling TK, Chung SC, Yung MY, Cheng AF, Sung JJ, Li AK. 1994 Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 343:508-510.
4. Shiota S, Yamaoka Y. 2010. Management of Helicobacter pylori. F1000 Med. Rep. 2:20-22.
5. Takenaka R, Okada H, Kato J, Makidono C, Hori S, Kawahara Y, Miyoshi M, Yumoto E, Imagawa A, Toyokawa T, Sakaguchi K, Shiratori Y. 2007. Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type. Aliment. Pharmacol. Ther. 25:805-812.
6. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. 2007. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56:772-781.
7. Mégraud F. 2004. H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53:1374-1384.
8. Debets-Ossenkopp YJ, Herscheid AJ, Pot RG, Kuipers EJ, Kusters JG, Vandenbroucke-Grauls CM. 1999. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline and trovafloxacin in The Netherlands. J. Antimicrob. Chemother. 43:511-515.
9. Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, Lam SK, Xiao SD, Tan HJ, Wu CY, Jung HC, Hoang BH, Kachintorn U, Goh KL, Chiba T, Rani AA, Second Asia-Pacific Conference. 2009. Second Asia-Pacific consensus guidelines for Helicobacter pylori infection. J. Gastroenterol. Hepatol. 24:1587-1600.
10. Glupczynski Y, Mégraud F, Lopez-Brea M, Andersen LP. 2001. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 20:820-823.
11. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ, European Helicobacter Study Group. 2012. Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report. Gut 61:646-664.
12. Jenks PJ. 2002. Causes of failure of eradication of Helicobacter pylori. BMJ 325:3-4.
13. Mégraud F, Lamouliatte H. 2003. Review article: the treatment of refractory Helicobacter pylori infection. Aliment. Pharmacol. Ther. 17: 1333-1343.
14. Vakil N, Megraud F. 2007. Eradication therapy for Helicobacter pylori. Gastroenterology 133:985-1001.